1-3 of 3
Thomas Kaley, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase Ib of Copanlisib in Combination with Ibrutinib in Recurrent/Refractory Primary CNS Lymphoma (PCNSL)

Christian Grommes, MD, Igor Gavrilovic, MD, Alexandra M Miller, MD PhD, Jacqueline B Stone, MD, Thomas Kaley, MD, Juli T Madzsar, Alyssa Schumpp, Brittany T Butler, Lauren Schaff, MD, Ingo K Mellinghoff, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1598.
https://doi.org/10.1182/blood-2019-126214
Published: 2019
Journal Articles

Phase II of Single-Agent Ibrutinib in Recurrent/Refractory Primary (PCNSL) and Secondary CNS Lymphoma (SCNSL)

Christian Grommes, MD, Julia Wolfe, Igor Gavrilovic, MD, Thomas Kaley, MD, Jacqueline Stone, MD, Mariza Daras, MD, Craig Nolan, MD, Elena Pentsova, MD, Vaios Hatzoglou, MD, Ingo Mellinghoff, MD, Lisa DeAngelis, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2965.
https://doi.org/10.1182/blood-2018-99-118538
Published: 2018
Journal Articles

Single-Agent Ibrutinib in Recurrent/Refractory Central Nervous System Lymphoma

Christian Grommes, MD, Alessandro Pastore, MD, Igor Gavrilovic, MD, Thomas Kaley, MD, Craig Nolan, MD, Antonio M. Omuro, MD, Julia Wolfe, Elena Pentsova, MD, Vaois Hatzoglou, MD, Ingo Mellinghoff, MD, Lisa DeAngelis, MD
Journal: Blood
Blood (2016) 128 (22): 783.
https://doi.org/10.1182/blood.V128.22.783.783
Published: 2016